Total submissions: 1
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Ambry Genetics | RCV002317965 | SCV000849501 | uncertain significance | Inborn genetic diseases | 2020-02-03 | criteria provided, single submitter | clinical testing | The p.S116T variant (also known as c.347G>C), located in coding exon 1 of the NRXN1 gene, results from a G to C substitution at nucleotide position 347. The serine at codon 116 is replaced by threonine, an amino acid with similar properties. This amino acid position is not well conserved in available vertebrate species. In addition, this alteration is predicted to be tolerated by in silico analysis. Since supporting evidence is limited at this time, the clinical significance of this alteration remains unclear. |